Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alloy vs PauseRX

Alloy
Graded #80

Higher grade

vs+3.700000000000003
PauseRX
Graded #147

Lower grade

The verdict

Alloy takes it — 72.2/100 to 68.5/100.

Alloy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlloy +4
70
66
Dose & formulationAlloy +8
93
85
Clinical oversightPauseRX +4
79
83
Labs & monitoringAlloy +2
54
52
FulfillmentAlloy +4
65
61
Contract termsAlloy +14
55
41
Alloy · left barPauseRX · right bar

The numbers

MetricAlloyPauseRX
WeighScore72.2/10068.5/100
GradeCC
Scorecard rank#80#147
Semaglutide$169/mo (compounded)$199/mo
Tirzepatide$199/mo (compounded)$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
Alloy

Graded #80 · C

Strengths

  • Broadest GLP-1 formulary here: brand Wegovy and Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide, and liraglutide
  • All consulting doctors are certified by The Menopause Society — a rare credential
  • STARTGLP1 promo code takes $50 off the first month
  • Spans the price range: compounded semaglutide from $70/mo, brand Wegovy from $199/mo (each plus the $99/mo Weight Care fee)

Where it loses points

  • Menopause-focused — best for women in menopause or perimenopause, not men or younger patients
  • A mandatory $99/mo Alloy Weight Care fee sits on top of every medication price (so the true minimum is ~$169/mo, not $70)
  • Compounded semaglutide not available in AL, AR, CA, NV, LA, MS or DC
PauseRX

Graded #147 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard